Fig. 1 PIK3CA and PIK3R1 protein structures and distribution of identified variants. (a) PIK3R1 protein (p85) and its functional domains. Variants localized in the nSH2 domain (n = 1) and in the PI3K_P85_iSH2 domain (n = 3). L570P and L573P variants are predicted to be pathogenic but lack experimental validation. (b) PIK3CA (p110) and its functional domains. Variants reported in black localized in the Ca2+-binding domain (n = 2) and in PI3K catalytic domain (n = 1). Hotspot PIK3CA mutations are in grey. Cancer hotspot regions are highlighted in light blue. Ca2+, calcium ion; PI3K, phosphoinositide 3-kinase.
Image
Figure Caption
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J. Invest. Dermatol.